Selenium supplementation for management of gestational diabetes mellitus in pregnancy: a systematic review and meta-analysis of randomized controlled trials.
- 2025-10-10
- Meta-Analysis · n = 230
- BMC endocrine disorders 25(1)
- Juan Sun
- Lei Liu
- Juxiang Shen
- Juan Du
- PubMed: 41073938
- DOI: 10.1186/s12902-025-02045-5
- High evidence
- Clinical
Compared with placebo group, the selenium group did not significantly reduce the level of homeostasis model assessment of insulin resistance(P = 0.20, MD = -0.71, 95%CI: -1.80, 0.37)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 100 µg/day to 200 µg/day